CollPlant Biotechnologies Ltd.
CLGN
$2.71
$0.083.04%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 689.00K | 10.62M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 689.00K | 10.62M | |
| Cost of Revenue | -- | -- | 2.13M | 2.21M | |
| Gross Profit | -- | -- | -1.44M | 8.41M | |
| SG&A Expenses | -- | -- | 6.05M | 5.95M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 19.09M | 18.95M | |
| Operating Income | -- | -- | -18.41M | -8.32M | |
| Income Before Tax | -- | -- | -17.47M | -7.50M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -- | -17.47 | -7.50 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -17.47M | -7.50M | |
| EBIT | -- | -- | -18.41M | -8.32M | |
| EBITDA | -- | -- | -17.31M | -7.22M | |
| EPS Basic | -- | -- | -1.53 | -0.65 | |
| Normalized Basic EPS | -- | -- | -0.49 | 0.06 | |
| EPS Diluted | -- | -- | -1.53 | -0.67 | |
| Normalized Diluted EPS | -- | -- | -0.49 | 0.05 | |
| Average Basic Shares Outstanding | -- | -- | 45.80M | 45.72M | |
| Average Diluted Shares Outstanding | -- | -- | 45.80M | 46.13M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |